NextCell Pharma

18/09/2023

NextCell Pharma was invited to present at the Advanced Therapies Europe, a European conference in Portugal on advanced cell therapies. NextCell participated through CEO Mathias Svahn and CSO Lindsay Davies who was sharing NextCell's research on the cell therapy drug ProTrans for the treatment of type 1 diabetes.

04/01/2023

Fantastiskt vinterprat av Olof Wretling om typ-1 diabetes.

Komikern om likheterna mellan en diabetespappa och Indiana Jones.

04/01/2023

Fantastiskt vinterprat av Olof Wretling om typ-1 diabetes.

Hör skådespelaren Olof Wretling berätta hur det var när de upptäckte att sonen hade diabetes typ-1. Han målar upp likheterna mellan en diabetespappa och Indiana Jones på ett dramatiskt och humoristiskt sätt. 😘

Lyssna på Vinter i P1 med Olof Wretling!
sverigesradio.se/avsnitt/olof-wretling-vinterprat-2022

14/11/2022

Living With Diabetes launched today, aiming to highlight the innovations surrounding remission, education, diagnosis of diabetes and much more.
💙
Visit https://bit.ly/3h9LZ4c to read more about NextCell Pharma's drug candidate in an article written by Elin and Emma .bygden at .
💙
Visit https://www.healthawareness.co.uk/diabetes/ for insightful content from Diabetes UK , IDF, JDRF and ABCD.

27/10/2022

🔊 NextCell cell therapy shows long-term effect in two independent diabetes studies "ProTrans-Repeat" and "ProTrans-Obs" 🔊

NextCell Pharma AB has developed a proprietary and patented platform technology where stem cells can be selected for allogeneic treatment of various specific diseases. CEO Mathias Svahn will present the results on Thursday, October 27 at 15:00 CET, which will be broadcast live via Nyhetsbyrån Direkt, link: https://buff.ly/3szcOBd

10/01/2020

Har du nyligen fått diabetes typ 1 och vill delta i en forskningsstudie?
Vi söker dig man som är 18 till 40 år

Läs mer på:
https://karolinskatrialalliance.se/har-du-nyligen-fatt-diabetes-typ-1-och-vill-delta-i-en-forskningsstudie-2/